Vivimed Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE526G01021
  • NSEID: VIVIMEDLAB
  • BSEID: 532660
INR
6.39
-0.12 (-1.84%)
BSENSE

May 13

BSE+NSE Vol: 38.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 612893,
    "name": "Vivimed Labs.",
    "stock_name": "Vivimed Labs.",
    "full_name": "Vivimed Labs Ltd",
    "name_url": "stocks-analysis/vivimed-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6.39",
    "chg": -0.12,
    "chgp": "-1.84%",
    "dir": -1,
    "prev_price": "6.51",
    "mcapval": "51.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532660,
    "symbol": "VIVIMEDLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE526G01021",
    "curr_date": "May 13",
    "curr_time": "",
    "bse_nse_vol": "38.48 k",
    "exc_status": "Active",
    "traded_date": "May 13, 2026",
    "traded_date_str": "2026 05 13",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/vivimed-labs-612893-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Vivimed Labs Ltd Downgraded to Strong Sell Amidst Weak Financials and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivimed-labs-ltd-downgraded-to-strong-sell-amidst-weak-financials-and-technical-setbacks-3988818",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivimedLabsLtd_mojoScore_3988818.png",
        "date": "2026-05-13 08:10:12",
        "description": "Vivimed Labs Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 12 May 2026, reflecting deteriorating fundamentals and a shift in technical indicators. The micro-cap pharmaceutical company’s financial performance remains flat with mounting debt concerns, while technical trends have shifted from mildly bullish to sideways, signalling caution for investors."
      },
      {
        "title": "Vivimed Labs Gains 1.78%: Technical Shift and Upper Circuit Spark Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-gains-178-technical-shift-and-upper-circuit-spark-interest-3983518",
        "imagepath": "",
        "date": "2026-05-09 16:09:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Week opens at Rs.6.76</p>\n                    <p><strong>5 May:</strong> Rating upgraded to ‘Sell’ on technical improvements</p>\n                    <p><strong>7 May:</strong> Stock hits upper circuit at Rs.7.02 amid strong buying</p>\n                    <p><strong>8 May:</strong> Week closes at Rs.6.88, up 1.78%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.6.76</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.6.88</div><div class=\"stat-change positive\">+1.78%</di..."
      },
      {
        "title": "Vivimed Labs Ltd Locks at Upper Circuit With 3.14% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-3979391",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivimedLabsLtd_stocks_hitting_upper_circuit_3979391.png",
        "date": "2026-05-07 10:00:31",
        "description": "At Rs 7.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 3.14% on 7 May 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Vivimed Labs Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivimed-labs-ltd-upgraded-to-sell-on-technical-improvements-despite-weak-fundamentals-3977079",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/VivimedLabsLtd_mojoScore_3977079.png",
        "date": "2026-05-06 08:08:05",
        "description": "Vivimed Labs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The micro-cap pharmaceutical company’s technical outlook has improved to mildly bullish, prompting a reassessment of its market stance, even as financial and valuation metrics remain under pressure."
      },
      {
        "title": "Vivimed Labs Ltd Downgraded to Strong Sell Amid Weak Financials and Technical Deterioration",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivimed-labs-ltd-downgraded-to-strong-sell-amid-weak-financials-and-technical-deterioration-3963738",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VivimedLabsLtd_mojoScore_3963738.png",
        "date": "2026-04-27 08:03:40",
        "description": "Vivimed Labs Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating fundamentals and a shift in technical indicators. The company’s micro-cap status, combined with weak financial trends and bearish technical signals, has prompted analysts to revise their outlook, signalling caution for investors amid ongoing challenges."
      },
      {
        "title": "Vivimed Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/vivimed-labs-ltd-is-rated-strong-sell-3963084",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VivimedLabsLtd_mojoScore_3963084.png",
        "date": "2026-04-26 10:10:24",
        "description": "Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 April 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 26 April 2026, providing investors with the most up-to-date analysis."
      },
      {
        "title": "Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3956956",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VivimedLabsLtd_stocks_hitting_lower_circuit_3956956.png",
        "date": "2026-04-22 10:00:09",
        "description": "At Rs 6.89, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 5% on 22 Apr 2026, with unfilled sell orders and a frozen price."
      },
      {
        "title": "Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3953985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/VivimedLabsLtd_stocks_hitting_lower_circuit_3953985.png",
        "date": "2026-04-20 11:00:05",
        "description": "At Rs 7.37, Vivimed Labs Ltd locked at its lower circuit of 5% on 20 Apr 2026, with unfilled sell orders and a frozen price. Sellers were lined up to exit, but buyers were absent, creating a supply glut that halted further declines."
      },
      {
        "title": "Vivimed Labs Gains 15.75%: 3 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/vivimed-labs-gains-1575-3-key-factors-driving-the-weeks-rally-3952560",
        "imagepath": "",
        "date": "2026-04-18 16:05:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>13 Apr:</strong> Technical upgrade to Sell rating by MarketsMOJO</p>\n                    <p><strong>15 Apr:</strong> Stock hits upper circuit, closing at ₹7.55 (+4.96%)</p>\n                    <p><strong>17 Apr:</strong> Another upper circuit surge, closing at ₹7.79 (+4.99%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹6.73</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">₹7.79</div><div class=\"stat-change positive\">+15.75%</div></div>\n                    <div class=\"stat-item\"><div c..."
      }
    ],
    "total": 107,
    "sid": "612893",
    "stock_news_url": "https://www.marketsmojo.com/news/vivimed-labs-612893"
  },
  "announcements": [
    {
      "caption": "Corporate Insolvency Resolution Process (CIRP)-Public Announcement",
      "datetime": "23-Apr-2026",
      "details": "Form A - Public Announcement",
      "source": "BSE"
    },
    {
      "caption": "Admission To CIRP",
      "datetime": "17-Apr-2026",
      "details": "ADMISSION TO CIRP",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "certificate under reg 74(5)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has declared <strong>20%</strong> dividend, ex-date: 19 Sep 18",
          "dt": "2018-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Vivimed Labs Ltd has announced <strong>2:10</strong> stock split, ex-date: 06 Apr 16",
          "dt": "2016-04-06",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Vivimed Labs Gains 1.78%: Technical Shift and Upper Circuit Spark Interest

2026-05-09 16:09:17

Key Events This Week

4 May: Week opens at Rs.6.76

5 May: Rating upgraded to ‘Sell’ on technical improvements

7 May: Stock hits upper circuit at Rs.7.02 amid strong buying

8 May: Week closes at Rs.6.88, up 1.78%

stock-recommendationAnnouncement

Corporate Insolvency Resolution Process (CIRP)-Public Announcement

23-Apr-2026 | Source : BSE

Form A - Public Announcement

Admission To CIRP

17-Apr-2026 | Source : BSE

ADMISSION TO CIRP

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

08-Apr-2026 | Source : BSE

certificate under reg 74(5)

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Vivimed Labs Ltd has declared 20% dividend, ex-date: 19 Sep 18

stock-summary
SPLITS

Vivimed Labs Ltd has announced 2:10 stock split, ex-date: 06 Apr 16

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available